MannKind | MNKD - EPS Earnings Per Share


MannKind reported $0.01 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.01 0.07 May/13
FY2025Q4 Dec/2025 0.01 0.01 0.08 Feb/26
FY2025Q3 Sep/2025 0.07 0.02 0.06 Nov/05
FY2025Q2 Jun/2025 0.05 0.05 0.05 Aug/06
FY2025Q1 Mar/2025 0.07 0.03 0.04 May/08




Eps Change Date
Adma Biologics USD 0.2 0.05 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
MannKind USD 0.01 0.06 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Novavax USD 0.13 0.59 Dec/2025
Novo Nordisk DKK 1.02 0.1 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Xencor USD -0.09 0.01 Dec/2025